New Xiidra Approved for Dry Eyes

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

Dry eyes typically affect adults starting in their 30s, and become more common as you age. Several other factors can contribute, including certain medications, and being contact lens wearer. Women are also more prone to dry eyes.

Now, if you suffer from dry eyes, you may know that there aren’t that many prescription options out there. Individually packaged Restasis (cyclosporine) drops may be your only choice in some cases. New medications are being developed, but unfortunately they aren’t the type of treatment drug companies are running to the lab to create—despite Restasis’s high price.

This may help: recently the FDA approved Xiidra (lifitegrast), a first of its kind dry eye treatment.

How is Xiidra used?

You’ll use one drop of Xiidra in each eye, twice daily (approximately 12 hours apart).

How will Xiidra be available?
Xiidra is a 5% ophthalmic solution, and will be available in cartons of indivual doses.

What are the side effects of Xiidra?

The most common side effects associated with Xiidra include eye irritation, discomfort, burred vision, and altered taste sensation.

When will Xiidra be available?
Xiidra was approved in July 2016, and is expected to become available in pharmacies in the 3rd quarter of 2016.

Is there anything unique about Xiidra?

Yes. Xiidra is the first medication in a new class of drugs called lymphocyte function-associated antigen 1 (LFA-1) antagonists. Xiidra is also the first medication that can be used to treat BOTH the signs and symptoms of dry eye disease. That may seem like a small distinction, but other treatments out there actually help dry eyes by reducing inflammation.

Want more information?

Check out the press release from the manufacturer Shire here, or take a look at the FDA announcement here.

Drugs featured in this story

Filed under